Grant: Project Grant
McMaster University
$100,000.00
Genetic and molecular determinants of early onset coronary artery disease.
FY 2016-17
Summary
Premature heart disease is particularly distressing to patients and their families. While a genetic cause is suspected in most cases, a specific gene is identified in less than 5% of cases because no guidelines help doctors decide which genes to test and how. Our project aims to define how best to screen for genetic mutations in individuals with premature heart disease, defined as having either an heart attack or angina before the age of 40 in males and 45 in females. To do so, we will recruit patients from the Hamilton region and perform detailed genetic characterization as well as blood tests. We will further collect cells from these patients and study these cells in test tubes to better understand how genetic mutations can lead to heart disease. Our hope is that the project will provide doctors with clear recommendations on how to genetically test patients with premature heart disease. This will allow us to screen relatives of affected family members to determine at-risk individuals, and in certain cases to offer preventative treatment tailored to a specific genetic condition.
Department
Program
Project Grant
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
351816
Name
Paré Guillaume
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Project Grant Competition
Projecttitle
Genetic and molecular determinants of early onset coronary artery disease.
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Atherosclerosis; Biomarkers; Coronary Artery Disease; Exome Sequencing; Genetics; Stem Cells; Thrombosis
Abstract
Premature heart disease is particularly distressing to patients and their families. While a genetic cause is suspected in most cases, a specific gene is identified in less than 5% of cases because no guidelines help doctors decide which genes to test and how. Our project aims to define how best to screen for genetic mutations in individuals with premature heart disease, defined as having either an heart attack or angina before the age of 40 in males and 45 in females. To do so, we will recruit patients from the Hamilton region and perform detailed genetic characterization as well as blood tests. We will further collect cells from these patients and study these cells in test tubes to better understand how genetic mutations can lead to heart disease. Our hope is that the project will provide doctors with clear recommendations on how to genetically test patients with premature heart disease. This will allow us to screen relatives of affected family members to determine at-risk individuals, and in certain cases to offer preventative treatment tailored to a specific genetic condition.
Competitiondate
201604
Approvedterm2
1 yr 0 mth
Pinamesdelim
Paré, Guillaume
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $100,000~ $0~